This manual provides detailed information on using the Lenti-X™ Tet-On® Advanced Inducible Expression System. The manual describes how the Lenti-X™ Tet-On® Advanced Inducible Expression System can be constructed and characterized in mammalian cells.
The Lenti-X Tet-On Advanced Inducible Expression System utilizes lentiviral-based gene transfer technology to deliver a tightly regulated and highly responsive gene expression system into dividing and nondividing target cells, primary cells, and stem cells. The system includes a novel transactivator and an improved inducible promoter to control gene expression levels.
The concentration of the system's inducer, doxycycline (Dox), is adjusted to control the expression level of the gene of interest.
The system delivers the gene expression system into dividing and nondividing target cells, primary cells, and stem cells.
The system produces very high titer supernatants containing infectious, replication-incompetent lentiviruses.